ES2055687T3 - Vacuna de virus. - Google Patents
Vacuna de virus.Info
- Publication number
- ES2055687T3 ES2055687T3 ES86307768T ES86307768T ES2055687T3 ES 2055687 T3 ES2055687 T3 ES 2055687T3 ES 86307768 T ES86307768 T ES 86307768T ES 86307768 T ES86307768 T ES 86307768T ES 2055687 T3 ES2055687 T3 ES 2055687T3
- Authority
- ES
- Spain
- Prior art keywords
- virus vaccine
- various animals
- virus
- vaccinated
- vaccines
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 241000700605 Viruses Species 0.000 title abstract 3
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 241001465754 Metazoa Species 0.000 abstract 2
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 230000004069 differentiation Effects 0.000 abstract 1
- 230000000405 serological effect Effects 0.000 abstract 1
- 229960004854 viral vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16721—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Urology & Nephrology (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Plant Pathology (AREA)
- Cell Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
LA INVENCION SE REFIERE A UNA VACUNA VIRICA QUE CONSISTE EN UN VIRUS ADECUADAMENTE INCAPACITADO AL QUE LE FALTA UN ANTIGENO DEL VIRUS NATIVO, QUE ES UTIL PARA LA DIFERENCIACION SEROLOGICA ENTRE ANIMALES VACUNADOS E INFECTADOS, A METODOS PARA REALIZAR DICHA DIFERENCIACION Y A VACUNAS MULTIVALENTES.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP86307768A EP0263207B1 (en) | 1986-10-08 | 1986-10-08 | Virus vaccine |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2055687T3 true ES2055687T3 (es) | 1994-09-01 |
Family
ID=8196175
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES86307768T Expired - Lifetime ES2055687T3 (es) | 1986-10-08 | 1986-10-08 | Vacuna de virus. |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP0263207B1 (es) |
ES (1) | ES2055687T3 (es) |
GR (1) | GR3003377T3 (es) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4603112A (en) * | 1981-12-24 | 1986-07-29 | Health Research, Incorporated | Modified vaccinia virus |
NL8303501A (nl) * | 1983-10-12 | 1985-05-01 | Centraal Diergeneeskundig Inst | Deletiemutant van een herpesvirus en vaccin, dat dit virus bevat. |
US4514497B1 (en) * | 1983-12-30 | 1998-02-24 | Novagene Inc | Modified live pseudorabies viruses |
AU591145B2 (en) * | 1985-07-29 | 1989-11-30 | Pharmacia & Upjohn Company | Virus vaccine with deletion of an antigen of the wild-type virus |
-
1986
- 1986-10-08 ES ES86307768T patent/ES2055687T3/es not_active Expired - Lifetime
- 1986-10-08 EP EP86307768A patent/EP0263207B1/en not_active Expired - Lifetime
-
1991
- 1991-12-18 GR GR91402062T patent/GR3003377T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP0263207B1 (en) | 1991-11-27 |
EP0263207A1 (en) | 1988-04-13 |
GR3003377T3 (en) | 1993-02-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0584348T3 (da) | Genetisk vaccine mod immundefektvirusser | |
ES2083764T3 (es) | Vacuna contra el sindrome respiratorio reproductivo porcino (srrp) y diagnostico. | |
DE68927348D1 (de) | Künstlicher impfstoff gegen aids-virus | |
ATE60799T1 (de) | Virus-impfstoff. | |
ES2070997T3 (es) | Virus de herpes recombinante de pavos y vacunas vector vivas derivadas de los mismos. | |
SE9102975L (sv) | Bakterofag och vaerd till anvaendning foer framstaellning av hiv-proteiner och peptider | |
AR003135A1 (es) | Baculovirus recombinante, una vacuna que los contiene, y el uso del mismo para preparar una vacuna util para evitar o disminuir la enfermedad causada porvirus de inmunodeficiencia felina. | |
ES2042828T3 (es) | Procedimiento de preparacion de vacunas contra tumores modificadas por virus para la inmunoterapia de metastasis de tumores. | |
ES2058283T3 (es) | Vacuna contra coronavirus canino. | |
ES2061603T3 (es) | Mutantes viricos de la rinotraqueitis bovina infecciosa, vacunas que los contienen, metodos para la produccion de los mismos y metodos para el empleo de los mismos. | |
ES2063897T5 (es) | Vacuna contra el virus del colera porcino y diagnostico. | |
AR248046A1 (es) | Biosintesis de una secuencia de adn codificante de una glicoproteina inmunogena de hospedantes de garrapatas, sonda de hibridizacion, moleculas de dna, transformantes y plasmidos. | |
ES2055687T3 (es) | Vacuna de virus. | |
ES2059305T5 (es) | Proteina del virus de la seudorrabia. | |
NO175846C (no) | Fremgangsmåte for å oppnå et immunogen | |
GB2227936A (en) | Vaccine against brucella abortus | |
AR019785A1 (es) | Pestivirus no diseminantes | |
ES500199A0 (es) | Un procedimiento para preparar una vacuna de virus de la ra-bia inactivados | |
ES2095258T3 (es) | Nuevo virus de la enfermedad de la bolsa infecciosa. | |
ES2074965B1 (es) | Virus mutante recombinante de rinotraqueitis infecciosa bovina y vacunas que lo contienen. | |
SE9202934D0 (sv) | Vacciner mot melanom | |
ES482549A0 (es) | Un metodo para la preparacion de una composicion de virus herpes | |
KR920007636A (ko) | 신규의 백신체 | |
GT198500078A (es) | Vacuna polivalente inmuno-estimulante | |
PT90800A (pt) | Processo para a preparacao de antigenios precursores das glicoproteinas de involucro de um retrovirus humano hiv-2 e de antigenios que apresentem uma analogia imonulogiga com estes ultimos e sua aplicacao ao diagnostico |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 263207 Country of ref document: ES |